Cath Lab Digest

Elmarco s.r.o. (Czech Republic), a global producer of machinery focused on industrial scale nanofiber production and HemCon Medical Technologies Inc (Portland, Ore) recently entered an exclusive partnership agreement to develop and commercialize products manufactured using the Elmarco Nanospider platform for the wound care market.

Nanospider machines offer production-level manufacturing of high quality fibers, unlike current electro-spinning processes, which create nano-sized fibers one at a time. The patented Nanospider manufacturing technology provides increased productivity and efficiencies while reducing raw material requirements, production time, and labor costs. The use of nanofiber materials for wound care enables the creation of complex layered dressings that can include multiple therapeutic benefits in a single product.

Through the collaboration, HemCon will be the sole channel through which the Nanospider manufacturing platform will be utilized for the global wound care market and is valued at an estimated $5.5 billion. As exclusive partners, HemCon will provide product development scale up and design transfer expertise while Elmarco will offer its proprietary platform to the Nanospider for manufacturing and the transfer of technology within the field of wound care.

For more information, visit www.hemcon.com or www.elmarco.com.